Abstracts tagged "Autonomic disorders"

Abstract Number: 41 • 2016 ACR/ARHP Annual Meeting
Human Papilloma Virus Vaccination, Fibromyalgia and Dysautonomia
Manuel Martínez-Lavín¹, Paola-Kinara Reyes-Loyola² and Laura-Aline Martinez-Martinez³, ¹Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico, ²Rheumatology, National Institute of Cardiology, Mexico, Mexico, ³Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, TX, Mexico
Background/Purpose: In a questionnaire-based case series, we described the clinical features of 45 patients who had the onset of a chronic illness soon after HPV…
Abstract Number: 71 • 2015 ACR/ARHP Annual Meeting
Fibromyalgia Dysautonomia and Distress. Correlation Between the Newly Developed Composite Autonomic Symptoms (COMPASS-31) Questionnaire and the Fibromyalgia Polysymptomatic Distress Scale
Laura-Aline Martinez-Martinez¹, Maya Chacón Pérez², Paola Reyes-Loyola³ and Manuel Martínez-Lavín³, ¹National Institute of Cardiology. Mexico, Mexico City, TX, Mexico, ²National Institute of Cardiology, Mexico City, Mexico, ³National Institute of Cardiology. Mexico, Mexico City, Mexico
Background/Purpose: A consistent line of investigation suggests that dysautonomia may explain the multisystem fibromyalgia features, and that fibromyalgia is a sympathetically maintained neuropathic pain syndrome.…
Abstract Number: 75 • 2015 ACR/ARHP Annual Meeting
Fibromyalgia and Positional Cervical Cord Compression Differ Only By Autonomic Nervous System Consequences: A Double-Blinded, Prospective Study
Andrew Holman, Pacific Rheumatology Reseach, Seattle, WA
Background/Purpose: In 1998, C Muhle and D Resnick proposed a corollary to cervical spinal stenosis caused by intermittent abutment of the cervical spinal cord from…
Abstract Number: 442 • 2015 ACR/ARHP Annual Meeting
Use of Adjunctive Neuroregulatory Medication to Improve Etanercept Treatment Response for Patients with Inflammatory Arthritis: A Pilot Study
Andrew Holman¹ and Edmund Ng², ¹Inmedix, Normandy Park, WA, ²Statistical Thinking, Seattle, WA
Background/Purpose: As a proposed inflammatory biomarker for autoimmune disease1,2, the autonomic nervous system (ANS) has been assessed as a predictor of anti-TNF treatment outcome3 and…
Abstract Number: 1571 • 2015 ACR/ARHP Annual Meeting
How Substantive Is Heart Rate Variability As a Predictor of Anti-TNF Treatment Outcome for Inflammatory Arthritis?
Andrew Holman¹ and Edmund Ng², ¹Inmedix, Normandy Park, WA, ²Statistical Thinking, Seattle, WA
Background/Purpose: As rheumatologists search for new targets to improve immunosuppressive outcomes, the autonomic nervous system (ANS) as a co-factor in autoimmune disease expression has gained…
Abstract Number: 2068 • 2014 ACR/ARHP Annual Meeting
Joint Hypermobility Syndrome and Postural Orthostatic Tachycardia Syndrome (HyPOTS)
Artan Kaso and Ali Askari, Rheumatology, University Hospital Case Medical Center, Cleveland, OH
Background/Purpose Joint hypermobility syndrome (JHS) is a chronically disabling disorder manifested as a widespread musculoskeletal pain and/or fatigue, in the presence of generalized joint hypermobility.…
Abstract Number: 145 • 2013 ACR/ARHP Annual Meeting
Autonomic Nervous System “Decomplexification” In Fibromyalgia. A Proof Of Concept Study Looking At The Fractality Of Heart Rhythms
Manuel Martinez-Lavin¹, Claudia Lerma², Laura Aline Martinez-Martinez³, Oscar Infante² and Angelica Vargas³, ¹Chief Rheumatology, National Institute of Cardiology, Mexico City, Mexico, ²National Institute of Cardiology, Mexico City, Mexico, ³Rheumatology, National Institute of Cardiology, Mexico City, Mexico
Background/Purpose: Prevailing linear-reductionist medical model seems unable to explain complex diseases like fibromyalgia (FM) and similar maladies. As consequence of this divorce, some physicians disparage…
Abstract Number: 1597 • 2013 ACR/ARHP Annual Meeting
Autonomic Dysfunction In Systemic Lupus Erythematosus Patients With Previous Neuropsychiatric Involvement
Yang Gao, Sheung Wei Li, Lai Heung Chau, Chak Sing Lau and Mo Yin Mok, Department of Medicine, University of Hong Kong, Hong Kong, Hong Kong
Background/Purpose: Autonomic dysfunction has increasingly been described to be associated with central nervous system (CNS) disorders and has been attributed to damage of the central…
Abstract Number: 1218 • 2012 ACR/ARHP Annual Meeting
Genetic Markers of Functional Stress Response in Patients with Rheumatoid Arthritis
Olga Malysheva and Christoph G. Baerwald, Rheumatology, University Hospital, Leipzig, Germany
Background/Purpose: Stress is recognized as an important risk factor in the pathogenesis of rheumatoid arthritis (RA). However, it is still incompletely understood how the stress…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].